[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL1625163T3 - Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43 - Google Patents

Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43

Info

Publication number
PL1625163T3
PL1625163T3 PL04732278T PL04732278T PL1625163T3 PL 1625163 T3 PL1625163 T3 PL 1625163T3 PL 04732278 T PL04732278 T PL 04732278T PL 04732278 T PL04732278 T PL 04732278T PL 1625163 T3 PL1625163 T3 PL 1625163T3
Authority
PL
Poland
Prior art keywords
amino acids
monoclonal antibody
antibody binding
probnp
native probnp
Prior art date
Application number
PL04732278T
Other languages
English (en)
Inventor
Volker Klemt
Anneliese Borgya
Andreas Gallusser
Michael Grol
Klaus Hallermayer
Christoph Seidel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33427054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1625163(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL1625163T3 publication Critical patent/PL1625163T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL04732278T 2003-05-12 2004-05-12 Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43 PL1625163T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03010591 2003-05-12
EP04732278A EP1625163B8 (en) 2003-05-12 2004-05-12 Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-43
PCT/EP2004/005091 WO2004099252A1 (en) 2003-05-12 2004-05-12 Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44

Publications (1)

Publication Number Publication Date
PL1625163T3 true PL1625163T3 (pl) 2012-01-31

Family

ID=33427054

Family Applications (3)

Application Number Title Priority Date Filing Date
PL04732278T PL1625163T3 (pl) 2003-05-12 2004-05-12 Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43
PL04732282T PL1625164T3 (pl) 2003-05-12 2004-05-12 Sposób wykrywania proBNP z użyciem przeciwciała monoklonalnego wiążącego się z aminokwasami 42-46
PL10172014T PL2256132T3 (pl) 2003-05-12 2004-05-12 Sposób wykrywania proBNP z zastosowaniem przeciwciała monoklonalnego

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL04732282T PL1625164T3 (pl) 2003-05-12 2004-05-12 Sposób wykrywania proBNP z użyciem przeciwciała monoklonalnego wiążącego się z aminokwasami 42-46
PL10172014T PL2256132T3 (pl) 2003-05-12 2004-05-12 Sposób wykrywania proBNP z zastosowaniem przeciwciała monoklonalnego

Country Status (16)

Country Link
US (4) US7264939B2 (pl)
EP (4) EP1625164B1 (pl)
JP (4) JP4430066B2 (pl)
KR (2) KR100857752B1 (pl)
CN (3) CN1784425A (pl)
AT (2) ATE517124T1 (pl)
AU (1) AU2004235974B2 (pl)
BR (1) BRPI0410261B8 (pl)
CA (2) CA2522747C (pl)
DK (3) DK1625164T3 (pl)
ES (3) ES2548327T3 (pl)
HK (1) HK1097855A1 (pl)
HU (1) HUE025169T2 (pl)
MX (1) MXPA05011826A (pl)
PL (3) PL1625163T3 (pl)
WO (2) WO2004099253A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
PL1625163T3 (pl) * 2003-05-12 2012-01-31 Hoffmann La Roche Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43
US20070037208A1 (en) * 2003-05-29 2007-02-15 Foote Robert S Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
DE10355731A1 (de) * 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP
DE602005001299T2 (de) * 2004-07-07 2008-02-07 Roche Diagnostics Gmbh Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
ES2548009T3 (es) 2007-01-25 2015-10-13 F. Hoffmann-La Roche Ag Uso de IGFBP-7 en la evaluación de la insuficiencia cardíaca
KR100836322B1 (ko) * 2007-08-31 2008-06-09 현대자동차주식회사 차량용 흡음재 제작장치 및 방법
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
CA2722485C (en) 2008-04-30 2018-02-13 F. Hoffmann-La Roche Ag Use of sfrp-3 in the assessment of heart failure
ES2512018T3 (es) 2009-07-27 2014-10-23 F. Hoffmann-La Roche Ag Utilización de mimecán en la evaluación de la insuficiencia cardiaca
KR20120101064A (ko) * 2009-11-13 2012-09-12 비쥐 메디신, 인코포레이티드 심근 경색의 위험 인자 및 예측
US8778699B2 (en) 2010-08-04 2014-07-15 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
WO2012166918A1 (en) 2011-05-31 2012-12-06 Idexx Laboratories, Inc. DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
JP6119607B2 (ja) * 2011-09-20 2017-04-26 コニカミノルタ株式会社 検体希釈用液、それを用いたキットおよび蛍光測定方法
US20140273273A1 (en) 2012-11-01 2014-09-18 Christie Mitchell Ballantyne Biomarkers to improve prediction of heart failure risk
CN103304665A (zh) * 2013-05-21 2013-09-18 上海贝西生物科技有限公司 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用
JP6682445B2 (ja) * 2014-10-10 2020-04-15 松森 昭 心不全患者の検出方法、心疾患の識別方法、心不全の検査試薬、心不全の検査キット、心不全を検出するための装置及び心不全を検出するためのプログラム
EP3360570A1 (en) 2017-02-13 2018-08-15 Roche Diagnostics GmbH Antibodies recognizing genetic variants
JP7203034B2 (ja) * 2017-10-02 2023-01-12 大塚製薬株式会社 アナライトの検出方法
CN112074738B (zh) * 2018-04-13 2024-08-16 共立制药股份有限公司 心力衰竭检测方法、心力衰竭检测用器具、夹心免疫检测法以及抗体的组合
CN108752480B (zh) * 2018-05-30 2022-03-29 中元汇吉生物技术股份有限公司 一种免疫原组合物、其制备方法及其用途
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
CN111487222B (zh) * 2019-01-28 2023-11-14 上海乐合生物科技有限公司 一种检测bnp的spr芯片的制备方法
CN114207444A (zh) 2019-08-13 2022-03-18 挪威金田有限公司 用于NT-proBNP定量的高灵敏度颗粒增强测定
WO2022069658A1 (en) 2020-09-30 2022-04-07 F. Hoffmann-La Roche Ag Circulating total-nt-probnp (glycosylated and unglycosylated nt-probnp) and its ratio with nt-probnp (unglycosylated nt-probnp) in the assessment of atrial fibrillation
CN112986586A (zh) * 2021-02-20 2021-06-18 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
CN112964885B (zh) * 2021-02-20 2022-11-11 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
JP2024538607A (ja) 2021-10-01 2024-10-23 ゲンティアン アクティーゼルスカブ サンプル中のn末端プロホルモンbnp(nt-プロbnp)の濃度を測定するための新規方法
CN118922721A (zh) 2022-03-18 2024-11-08 豪夫迈·罗氏有限公司 用于2型与1型急性心肌梗死的早期辨别的cMyBPC标志物组合
WO2023175152A1 (en) 2022-03-18 2023-09-21 Roche Diagnostics Gmbh Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
JP2665850B2 (ja) 1991-11-14 1997-10-22 塩野義製薬株式会社 hBNPのC端を認識するモノクロ−ナル抗体
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
GB9827348D0 (en) 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
CA2359667C (en) 1999-01-29 2009-10-20 Roche Diagnostics Gmbh Method of identifying n-terminal probnp
US20030219734A1 (en) 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US20040096919A1 (en) * 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
PL1625163T3 (pl) * 2003-05-12 2012-01-31 Hoffmann La Roche Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43

Also Published As

Publication number Publication date
PL2256132T3 (pl) 2016-08-31
KR20060003905A (ko) 2006-01-11
WO2004099253A1 (en) 2004-11-18
US20070099241A1 (en) 2007-05-03
US7264938B2 (en) 2007-09-04
JP2007535470A (ja) 2007-12-06
JP2013018784A (ja) 2013-01-31
HK1097855A1 (en) 2007-07-06
MXPA05011826A (es) 2006-01-26
ES2369008T3 (es) 2011-11-24
US7264939B2 (en) 2007-09-04
US7811770B2 (en) 2010-10-12
ES2548327T3 (es) 2015-10-15
PL1625164T3 (pl) 2011-12-30
EP1625163B8 (en) 2011-11-02
EP2256132A1 (en) 2010-12-01
CN1784425A (zh) 2006-06-07
CA2522747A1 (en) 2004-11-18
DK2256132T3 (en) 2015-07-13
WO2004099252A1 (en) 2004-11-18
KR100857752B1 (ko) 2008-09-11
JP5649631B2 (ja) 2015-01-07
CA2522378A1 (en) 2004-11-18
CN1832964A (zh) 2006-09-13
DK1625163T3 (da) 2011-12-05
JP5128125B2 (ja) 2013-01-23
EP2256132B1 (en) 2015-04-01
JP2010011860A (ja) 2010-01-21
BRPI0410261B8 (pt) 2021-07-27
ES2372282T3 (es) 2012-01-18
AU2004235974A1 (en) 2004-11-18
US20070117156A1 (en) 2007-05-24
BRPI0410261A (pt) 2006-05-16
EP1625163B1 (en) 2011-08-31
EP1625163A1 (en) 2006-02-15
ATE517124T1 (de) 2011-08-15
US7807380B2 (en) 2010-10-05
CN100497393C (zh) 2009-06-10
CA2522378C (en) 2011-03-29
US20060110775A1 (en) 2006-05-25
ATE522546T1 (de) 2011-09-15
CA2522747C (en) 2012-08-14
JP4834136B2 (ja) 2011-12-14
CN101967190A (zh) 2011-02-09
JP4430066B2 (ja) 2010-03-10
HUE025169T2 (en) 2016-02-29
EP1625164B1 (en) 2011-07-20
US20060110776A1 (en) 2006-05-25
EP2949669A1 (en) 2015-12-02
BRPI0410261B1 (pt) 2020-03-10
AU2004235974B2 (en) 2008-02-14
JP2007525427A (ja) 2007-09-06
DK1625164T3 (da) 2011-10-31
KR20080011467A (ko) 2008-02-04
EP1625164A1 (en) 2006-02-15

Similar Documents

Publication Publication Date Title
PL1625163T3 (pl) Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43
ATE486093T1 (de) Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt
ATE440868T1 (de) Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
JP2007525427A5 (pl)
DK1151304T3 (da) Fremgangsmåde til påvisning af N-terminalt proBNP
WO2004046194A3 (en) Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
EP1191337A3 (en) Immunoassay for measuring human C-peptide and kit therefor
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
EP2251356A3 (en) Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
WO2008125733A8 (en) Immunoassay for quantification of an unstable antigen selected from bnp and probnp
WO2009054091A1 (ja) ガストリン放出ペプチド前駆体に対する抗体及びその使用
WO2003027149A1 (fr) Anticorps et utilisation de ce dernier
WO2009044561A1 (ja) 抗proNT/NMNモノクローナル抗体
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
SE0202702L (sv) Immunotest för specifik bestämning av SCCA isoformer
EP1359161A3 (en) Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof
WO2004029094B1 (en) Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3
ATE405646T1 (de) Ein verfahren zum auffinden vom prostatakrebs
WO2003027150A1 (fr) Anticorps et son utilisation
TW200720655A (en) ELISA kit for diagnosting infectious bursal disease (IBD) and method using the same